The KnowU incorporates the sensor that the Company plans to submit to the FDA for clearance. This proprietary sensor has been tested and proven stable and accurate in the lab setting. It was included ...

A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data promises to shake up diabetes management. The device is being showcased at the ...

Know Labs’ first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor’s accuracy and medical application. SEATTLE--(BUSINESS WIRE) ...

Samsung's VP hinted at significant progress in developing non-invasive blood glucose tracking technology, potentially a game-changer for diabetes management Samsung confirmed it's working on an ...

Samsung has laid down the gauntlet with a bold declaration that progress on developing a non-invasive continuous glucose monitor is progressing swimmingly. A company executive claimed that positive ...

Echo Therapeutics, creator of a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system called Symphony and a transdermal drug delivery system called Prelude SkinPrep, recently ...

A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day. Subscribe to our newsletter for the ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU™, its wearable non-invasive continuous ...